Preoperative locoregional re-evaluation by endoscopic ultrasound in pancreatic ductal adenocarcinoma after neoadjuvant chemoradiation
- PMID: 16141999
- DOI: 10.1016/s0399-8320(05)82153-0
Preoperative locoregional re-evaluation by endoscopic ultrasound in pancreatic ductal adenocarcinoma after neoadjuvant chemoradiation
Abstract
Introduction: The accuracy of endoscopic ultrasound (EUS) for the diagnosis and staging of pancreatic ductal adenocarcinoma (PDA) has been confirmed. Chemo-radiotherpay (CRT) induces tumor changes which can limit the accuracy of EUS. The aim of our study was to analyze the efficacy of EUS following neoadjuvant CRT comparing findings with the pathology results.
Patients and methods: From November 1996 to October 2003, 45 patients with histologically proven and EUS-staged PDA were treated with neo-adjuvant CRT and radical surgery. All were restaged before surgery using both EUS and computed tomography. Fifteen patients were found to have developed distant metastases. Thirty patients finally underwent pancreaticoduodenectomy (N=24) or distal pancreatectomy (N=6).
Results: Following CRT, tumor stage was correctly assessed in 12 patients (40%). The most frequent misinterpretation was overestimation of tumor size (N=13, 43.3%). Locoregional vascular invasion of veins was suspected by EUS in 13 patients (43.3%) but surgical findings and the histological examination were both negative. Node status was correctly assessed in 27 patients (90%) but nodal involvement was found on the histological specimen in only 3 patients.
Conclusion: Preoperative EUS after neoadjuvant CRT for PDA does not enable reliable definitive selection of patients for surgery, probably due to radiation-induced pancreatic changes.
Similar articles
-
Preoperative assessment of pancreatic malignancy using endoscopic ultrasound.Abdom Imaging. 2003 Jul-Aug;28(4):556-62. doi: 10.1007/s00261-002-0072-9. Abdom Imaging. 2003. PMID: 14580100
-
Tumor Size Differences Between Preoperative Endoscopic Ultrasound and Postoperative Pathology for Neoadjuvant-Treated Pancreatic Ductal Adenocarcinoma Predict Patient Outcome.Clin Gastroenterol Hepatol. 2022 Apr;20(4):886-897. doi: 10.1016/j.cgh.2020.11.041. Epub 2020 Dec 3. Clin Gastroenterol Hepatol. 2022. PMID: 33278573 Free PMC article.
-
Mapping patterns of local recurrence after pancreaticoduodenectomy for pancreatic adenocarcinoma: a new approach to adjuvant radiation field design.Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1007-15. doi: 10.1016/j.ijrobp.2013.09.005. Int J Radiat Oncol Biol Phys. 2013. PMID: 24267969 Free PMC article.
-
Endoscopic ultrasonography for diagnosis and staging of pancreatic adenocarcinoma: key messages for clinicians.Minerva Med. 2014 Apr;105(2):121-8. Minerva Med. 2014. PMID: 24727876 Review.
-
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.Ann Thorac Surg. 2004 Oct;78(4):1152-60; discussion 1152-60. doi: 10.1016/j.athoracsur.2004.04.046. Ann Thorac Surg. 2004. PMID: 15464463 Review.
Cited by
-
Pancreatic head resectable adenocarcinoma: preoperative chemoradiation improves local control but does not affect survival.HPB (Oxford). 2011 Jan;13(1):64-9. doi: 10.1111/j.1477-2574.2010.00245.x. Epub 2010 Dec 7. HPB (Oxford). 2011. PMID: 21159106 Free PMC article.
-
Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.Cochrane Database Syst Rev. 2016 Sep 15;9(9):CD011515. doi: 10.1002/14651858.CD011515.pub2. Cochrane Database Syst Rev. 2016. PMID: 27631326 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
